Zomedica Pharmaceuticals Corp. (
TSX: V.ZOM,
ZOMHF,
Forum), on Tuesday announced its participation in the Bank of Merrill Lynch Animal Health Summit on Monday, February 26, 2018 in New York.
Chief Financial Officer Shameze Rampertab, is part of a panel discussion on “Innovation in Companion Animal Therapeutics” at 8:40 a.m. (EDT) and will be available to participate in one-on-one meetings to discuss Zomedica’s pipeline development and key milestones with investors registered to attend the conference.
More information can be found
here.
Zomedica is a veterinary pharmaceutical and health care solutions company, creating products for companion animals.
More information can be found
here.
Zomedica was in the news recently when the company announced its financial results for the three and nine months ended September 30, 2017.
Full Disclosure: Zomedica Pharmaceuticals Corp.
is a paid client of Stockhouse Publishing.